Literature DB >> 22126970

Vascular endothelial cadherin modulates renal interstitial fibrosis.

Ikuyo Yamaguchi1, Bie Nga Tchao, Megan L Burger, Muneharu Yamada, Toshitake Hyodo, Costanza Giampietro, Allison A Eddy.   

Abstract

BACKGROUND/AIMS: Renal interstitial fibrosis is a final common pathway of all chronic, progressive kidney diseases. Peritubular capillary rarefaction is strongly correlated with fibrosis. The adherens junction protein vascular endothelial cadherin (VE-cadherin) is thought to play a critical role in vascular integrity. We hypothesized that VE-cadherin modulates the renal microcirculation during fibrogenesis and ultimately affects renal fibrosis.
METHODS: Unilateral ureteral obstruction (UUO) was used as a renal fibrosis model in VE-cadherin heterozygote (VE+/-) and wild-type (WT) mice, and the kidneys were harvested at days 3, 7, and 14. Peritubular capillary changes and fibrogenesis were investigated.
RESULTS: VE+/- mice had lower levels of VE-cadherin protein than WT mice at 3 and 7, but not 14 days after UUO. Vascular permeability was significantly greater in VE+/- mice 7 days after UUO, while peritubular capillary density was not significantly different in VE+/- and WT mice. Interstitial myofibroblast numbers and collagen I and III mRNA levels were significantly higher in VE+/- mice, consistent with a stronger early fibrogenic response. Expression of the pericyte marker neuron-glial antigen 2 was upregulated after UUO, but was not greater in VE+/- mice compared to the WT mice.
CONCLUSION: Our data suggest that VE-cadherin controls vascular permeability and limits fibrogenesis after UUO.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22126970      PMCID: PMC3254033          DOI: 10.1159/000332026

Source DB:  PubMed          Journal:  Nephron Exp Nephrol        ISSN: 1660-2129


  45 in total

1.  Number of interstitial capillary cross-sections assessed by monoclonal antibodies: relation to interstitial damage.

Authors:  D Serón; E Alexopoulos; M J Raftery; B Hartley; J S Cameron
Journal:  Nephrol Dial Transplant       Date:  1990       Impact factor: 5.992

2.  International comparison of the relationship of chronic kidney disease prevalence and ESRD risk.

Authors:  Stein I Hallan; Josef Coresh; Brad C Astor; Arne Asberg; Neil R Powe; Solfrid Romundstad; Hans A Hallan; Stian Lydersen; Jostein Holmen
Journal:  J Am Soc Nephrol       Date:  2006-06-21       Impact factor: 10.121

Review 3.  Breaking the VE-cadherin bonds.

Authors:  Julie Gavard
Journal:  FEBS Lett       Date:  2008-12-04       Impact factor: 4.124

4.  Injury of the renal microvascular endothelium alters barrier function after ischemia.

Authors:  Timothy A Sutton; Henry E Mang; Silvia B Campos; Ruben M Sandoval; Mervin C Yoder; Bruce A Molitoris
Journal:  Am J Physiol Renal Physiol       Date:  2003-04-08

5.  Urokinase receptor modulates cellular and angiogenic responses in obstructive nephropathy.

Authors:  Guoqiang Zhang; Heungsoo Kim; Xiaohe Cai; Jesus M Lopez-Guisa; Peter Carmeliet; Allison A Eddy
Journal:  J Am Soc Nephrol       Date:  2003-05       Impact factor: 10.121

Review 6.  Renal fibrosis: novel insights into mechanisms and therapeutic targets.

Authors:  Peter Boor; Tammo Ostendorf; Jürgen Floege
Journal:  Nat Rev Nephrol       Date:  2010-09-14       Impact factor: 28.314

Review 7.  Macrophage diversity in renal injury and repair.

Authors:  Sharon D Ricardo; Harry van Goor; Allison A Eddy
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

Review 8.  Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy.

Authors:  Robert L Chevalier; Michael S Forbes; Barbara A Thornhill
Journal:  Kidney Int       Date:  2009-04-01       Impact factor: 10.612

9.  Peritubular capillary regression during the progression of experimental obstructive nephropathy.

Authors:  Ryuji Ohashi; Akira Shimizu; Yukinari Masuda; Hiroshi Kitamura; Masamichi Ishizaki; Yuichi Sugisaki; Nobuaki Yamanaka
Journal:  J Am Soc Nephrol       Date:  2002-07       Impact factor: 10.121

10.  Hypoperfusion of peritubular capillaries induces chronic hypoxia before progression of tubulointerstitial injury in a progressive model of rat glomerulonephritis.

Authors:  Makiko Matsumoto; Tetsuhiro Tanaka; Tokunori Yamamoto; Eisei Noiri; Toshio Miyata; Reiko Inagi; Toshiro Fujita; Masaomi Nangaku
Journal:  J Am Soc Nephrol       Date:  2004-06       Impact factor: 10.121

View more
  6 in total

Review 1.  Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease.

Authors:  Yujiro Kida; Bie Nga Tchao; Ikuyo Yamaguchi
Journal:  Pediatr Nephrol       Date:  2013-03-10       Impact factor: 3.714

Review 2.  Overview of the cellular and molecular basis of kidney fibrosis.

Authors:  Allison A Eddy
Journal:  Kidney Int Suppl (2011)       Date:  2014-11

3.  The involvement of autotaxin in renal interstitial fibrosis through regulation of fibroblast functions and induction of vascular leakage.

Authors:  Norihiko Sakai; Gretchen Bain; Kengo Furuichi; Yasunori Iwata; Miki Nakamura; Akinori Hara; Shinji Kitajima; Akihiro Sagara; Taito Miyake; Tadashi Toyama; Koichi Sato; Shiori Nakagawa; Miho Shimizu; Shuichi Kaneko; Takashi Wada
Journal:  Sci Rep       Date:  2019-05-15       Impact factor: 4.379

4.  Upregulation of Cortical Renin and Downregulation of Medullary (Pro)Renin Receptor in Unilateral Ureteral Obstruction.

Authors:  Stefanny M Figueroa; Mauricio Lozano; Carolina Lobos; Matthew T Hennrikus; Alexis A Gonzalez; Cristián A Amador
Journal:  Front Pharmacol       Date:  2019-11-14       Impact factor: 5.810

5.  Depleted HDAC3 attenuates hyperuricemia-induced renal interstitial fibrosis via miR-19b-3p/SF3B3 axis.

Authors:  Langtao Hu; Kai Yang; Xing Mai; Jiali Wei; Chunyang Ma
Journal:  Cell Cycle       Date:  2022-01-13       Impact factor: 5.173

Review 6.  The Role of Krüppel-like Factor 4 in Renal Fibrosis.

Authors:  Ben Ke; Afei Zhang; Xianfeng Wu; Xiangdong Fang
Journal:  Front Physiol       Date:  2015-11-12       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.